SLC25A31 | Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 31 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CCL25 | Chemokine (C-C motif) ligand 25 | Predicted secreted proteins
| | | | | Group enriched |
IRGC | Immunity-related GTPase family, cinema | Predicted intracellular proteins
| | | | | Tissue enriched |
CYP1A2 | Cytochrome P450, family 1, subfamily A, polypeptide 2 | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
FMR1NB | Fragile X mental retardation 1 neighbor | Predicted membrane proteins
| | | | | Tissue enriched |
FATE1 | Fetal and adult testis expressed 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
TXNDC2 | Thioredoxin domain containing 2 (spermatozoa) | Predicted intracellular proteins
| | | | | Tissue enriched |
KRT1 | Keratin 1 | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
CLPS | Colipase, pancreatic | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
RNF151 | Ring finger protein 151 | Predicted intracellular proteins
| | | | | Tissue enriched |
DDX4 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
SERPINA10 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
CYLC2 | Cylicin, basic protein of sperm head cytoskeleton 2 | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enriched |
RP1-139D8.6 | | Predicted intracellular proteins
| | | | | Tissue enriched |
ACTL7B | Actin-like 7B | Predicted intracellular proteins
| | | | | Tissue enriched |
DEFA1B | Defensin, alpha 1B | Cancer-related genes Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
PLA2G1B | Phospholipase A2, group IB (pancreas) | Candidate cardiovascular disease genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
SFTA3 | Surfactant associated 3 | Predicted intracellular proteins
| | | | | Group enriched |
DEFA3 | Defensin, alpha 3, neutrophil-specific | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enriched |
CSH1 | Chorionic somatomammotropin hormone 1 (placental lactogen) | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
TEX33 | Testis expressed 33 | Predicted intracellular proteins
| | | | | Tissue enriched |
C1orf68 | Chromosome 1 open reading frame 68 | Predicted intracellular proteins
| | | | | Tissue enriched |
PPP3R2 | Protein phosphatase 3, regulatory subunit B, beta | FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
IQCF5 | IQ motif containing F5 | Predicted membrane proteins
| | | | | Tissue enriched |
CALR3 | Calreticulin 3 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
C3orf30 | Chromosome 3 open reading frame 30 | Predicted intracellular proteins
| | | | | Tissue enriched |
ZG16B | Zymogen granule protein 16B | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM2 | ADAM metallopeptidase domain 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
HMGB4 | High mobility group box 4 | Predicted intracellular proteins
| | | | | Tissue enriched |
DEFA6 | Defensin, alpha 6, Paneth cell-specific | Plasma proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
FGB | Fibrinogen beta chain | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CCDC42 | Coiled-coil domain containing 42 | Predicted intracellular proteins
| | | | | Tissue enriched |
MS4A3 | Membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific) | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
SPATA19 | Spermatogenesis associated 19 | Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enriched |
SERPINA11 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
GH2 | Growth hormone 2 | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enriched |
C11orf71 | Chromosome 11 open reading frame 71 | Predicted intracellular proteins
| | | | | Tissue enriched |
PSG2 | Pregnancy specific beta-1-glycoprotein 2 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
INSL5 | Insulin-like 5 | Predicted secreted proteins
| | | | | Group enriched |
ACTL9 | Actin-like 9 | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enriched |
KRT10 | Keratin 10 | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
LDHC | Lactate dehydrogenase C | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
CTRL | Chymotrypsin-like | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
TSSK1B | Testis-specific serine kinase 1B | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
C17orf74 | Chromosome 17 open reading frame 74 | Predicted membrane proteins
| | | | | Tissue enriched |
SPANXB2 | SPANX family, member B2 | Predicted intracellular proteins
| | | | | Tissue enriched |
C12orf50 | Chromosome 12 open reading frame 50 | Predicted intracellular proteins
| | | | | Tissue enriched |
PDCL2 | Phosducin-like 2 | Predicted intracellular proteins
| | | | | Tissue enriched |
ZNRF4 | Zinc and ring finger 4 | Predicted membrane proteins
| | | | | Tissue enriched |
RNASE3 | Ribonuclease, RNase A family, 3 | Predicted secreted proteins
| | | | | Tissue enriched |